Join the Obstructive Sleep Apnea/Hypopnea Syndrome group to help and get support from people like you.
Obstructive Sleep Apnea/Hypopnea Syndrome News
Tonsil Removal Helps Kids With Snoring/Sleep Apnea
THURSDAY, March 20, 2025 – Removing the tonsils and adenoids can improve the sleep of kids with mild breathing problems that disturb their slumber, a new clinical trial reports. Children with sleep...
AAN: Obstructive Sleep Apnea Linked to Increased Incidence of Parkinson Disease
TUESDAY, March 4, 2025 – Obstructive sleep apnea (OSA) is associated with an increased risk for Parkinson disease (PD), according to a study scheduled for presentation at the annual meeting of the...
Tonsillectomy Effective for Nocturnal Enuresis in Children With Sleep Apnea
FRIDAY, Feb. 7, 2025 – For children with obstructive sleep apnea (OSA) with nocturnal enuresis (NE), the remission rate of NE is more than half for those undergoing adenoidectomy and/or...
Sleep Apnea Surgery Linked to Lower Risk for Car Accidents for Patients
TUESDAY, Jan. 28, 2025 – For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor vehicle accidents (MVA) compared with continuous...
Does Sleep Apnea Contribute to Car Crashes?
FRIDAY, Jan. 24, 2025 – Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems and diabetes. Add car wrecks to that list, a study...
FDA Approves Zepbound (tirzepatide) as the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity
INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound (tirzepatide) as the first and only...
FDA Approves Zepbound for Sleep Apnea in Patients With Obesity
MONDAY, Dec. 23, 2024 – The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA). In a news...
GLP-1 Receptor Agonist Zepbound Approved as First Drug for Obstructive Sleep Apnea in Individuals with Obesity
MONDAY, Dec. 23, 2024 – The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug...
Sleep-Disordered Breathing Linked to Larger Hippocampal Volume
WEDNESDAY, Dec. 18, 2024 – Sleep disordered breathing (SDB) is associated with larger hippocampal volumes, according to a study published online Dec. 18 in Neurology. Alberto R. Ramos, M.D., from...
Sleep Apnea May Change Parts of Brain, Speed Aging
THURSDAY, Dec. 19, 2024 – Sleep apnea is known to wreak havoc with the body, contributing to heart problems, diabetes and liver disease. The sleep disorder also appears to have direct effects on...
Nocturnal Enuresis More Common in Children With Sleep Apnea
TUESDAY, Dec. 3, 2024 – Nocturnal enuresis is more common in children with obstructive sleep apnea (OSA), according to a study published online Sept. 23 in Children. María Andreu-Codina, from U...
Sleep Apnea Increases Risk for Dementia in Older Adults Over Time
TUESDAY, Nov. 5, 2024 – Obstructive sleep apnea (OSA) contributes to dementia risk in older adults, particularly women, according to a study published online Oct. 22 in Sleep Advances. Tiffany J. ...
Sleep Apnea Could Raise Dementia Risk, Especially for Women
FRIDAY, Nov. 1, 2024 – Sleep apnea appears to increase a person's odds of developing dementia, a new study finds. The effect seems stronger among women compared to men, noted a research team from...
American Academy of Otolaryngology-Head and Neck Surgery, Sept. 28-Oct. 1
The annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery was held from Sept. 28 to Oct. 1 in Miami, drawing participants from around the world, including otolaryngologists,...
Behavior Change Intervention Via Mail Cuts Use of Sleep Medications in Older Adults
FRIDAY, Sept. 20, 2024 – A mailed knowledge mobilization and behavior change intervention can reduce the use of sedatives and improve sleep outcomes in older adults with insomnia, according to a...